Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,25858,36,3.30 [2.11-5.17],1.940820224701104e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",25270,35,2.91 [2.25-3.76],4.166962228578637e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA,Adenosine deaminase,26012,34,4.62 [2.76-7.73],5.761500602463765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADA2,Adenosine deaminase 2,25576,36,7.33 [4.62-11.63],2.4966969054791882e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,21822,29,2.41 [1.73-3.35],2.1588589853978933e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,25923,35,5.87 [2.69-12.80],8.491670442542594e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,22348,29,6.46 [3.80-10.98],5.417390241953518e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,25270,35,2.15 [1.56-2.98],3.680072708267816e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,22447,28,6.36 [2.88-14.05],4.780645762987549e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,21977,28,8.52 [4.18-17.37],3.7047989713648526e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,25928,36,6.55 [3.79-11.31],1.59235105542807e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,25620,34,2.47 [1.91-3.20],7.396077725804541e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,24908,32,2.18 [1.75-2.72],4.694944952345359e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AGRN,Agrin,25875,34,5.76 [3.34-9.93],2.9390891686866004e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AHNAK2,Protein AHNAK2,21875,29,5.15 [2.82-9.42],1.0142301949397517e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,21020,29,0.10 [0.05-0.23],9.645906885326353e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPT2,Angiopoietin-2,25954,34,4.28 [2.34-7.85],2.490869782588506e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,25832,34,5.34 [2.81-10.13],2.997998928912411e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ANXA5,Annexin A5,25058,33,3.52 [2.01-6.14],9.942113264763776e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOA4,Apolipoprotein A-IV,22491,28,2.92 [1.98-4.31],7.095470698923413e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",APOL1,Apolipoprotein L1,22460,29,0.27 [0.15-0.48],5.300800758266232e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AREG,Amphiregulin,25620,34,2.79 [1.94-4.03],3.6971005252243856e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,25571,33,9.24 [4.48-19.09],1.853508643952773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,22460,29,8.45 [3.31-21.59],8.111850076038193e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,22348,29,2.42 [1.74-3.35],1.334370557498583e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,25829,36,7.45 [3.84-14.46],2.8712142693542555e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B2M,Beta-2-microglobulin,22491,28,2.05 [1.52-2.76],2.318896622550258e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21875,29,9.85 [4.44-21.85],1.8850729921310084e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,25147,34,4.90 [2.99-8.05],3.3181240998891847e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BCAM,Basal cell adhesion molecule,25740,35,6.92 [3.48-13.72],3.204159004642001e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21977,28,7.11 [3.60-14.04],1.6489452359968232e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,25829,36,3.18 [2.06-4.92],1.7189394060276456e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,21931,28,7.72 [3.54-16.80],2.6226688372376054e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA12,Carbonic anhydrase 12,25620,34,6.76 [4.60-9.91],1.5542917762872711e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA14,Carbonic anhydrase 14,25954,34,5.40 [2.83-10.32],3.309756427199332e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CA9,Carbonic anhydrase 9,25954,34,3.61 [2.40-5.44],8.017407670132316e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALB1,Calbindin,25620,34,3.48 [2.09-5.77],1.4235918262223665e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,22407,29,2.28 [1.59-3.26],7.743790690431883e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,25743,35,3.35 [2.06-5.45],1.1506271054968797e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL15,C-C motif chemokine 15,26057,36,4.45 [2.84-6.98],8.3372266433791e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL21,C-C motif chemokine 21,25875,34,2.05 [1.49-2.80],8.016552393206966e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCL25,C-C motif chemokine 25,26012,34,4.04 [2.38-6.88],2.564789375636824e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN3,CCN family member 3,26025,36,7.80 [5.19-11.72],4.727806042006241e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN4,CCN family member 4,25954,34,5.06 [3.02-8.48],7.01611760410919e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CCN5,CCN family member 5,25740,35,9.40 [5.60-15.78],2.281835939076156e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD109,CD109 antigen,25740,35,7.90 [3.54-17.64],4.659817572632227e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,25174,36,5.64 [3.48-9.14],2.3326325244783537e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD160,CD160 antigen,26012,34,4.56 [2.91-7.13],3.140785731116153e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD164,Sialomucin core protein 24,25740,35,2.41 [1.71-3.41],6.278463009580718e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD200,OX-2 membrane glycoprotein,25705,33,9.07 [4.18-19.71],2.5300491294411483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD207,C-type lectin domain family 4 member K,25186,34,4.64 [2.60-8.26],1.884560359660092e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD27,CD27 antigen,25832,34,8.01 [5.26-12.22],3.7831419989084514e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,25571,33,3.91 [2.42-6.31],2.2420894571434786e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,25147,34,3.11 [1.98-4.89],9.21722457850787e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300C,CMRF35-like molecule 6,25967,35,8.16 [4.62-14.43],5.057621797698937e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD300E,CMRF35-like molecule 2,25860,34,5.69 [3.62-8.93],4.2974596472192736e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD302,CD302 antigen,25620,34,7.63 [4.39-13.27],5.592299843511728e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,25620,34,8.07 [4.45-14.61],5.537427361725581e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD46,Membrane cofactor protein,25566,36,5.18 [3.33-8.06],3.081122621266634e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD48,CD48 antigen,25832,34,9.00 [4.30-18.82],5.2767588341901134e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD55,Complement decay-accelerating factor,24838,36,5.10 [3.24-8.03],1.858789506457781e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,25967,35,8.96 [5.22-15.39],1.9414202318881838e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,26012,34,3.89 [2.79-5.42],9.446254528008757e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,22457,29,4.85 [2.57-9.16],1.1671516956720874e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD83,CD83 antigen,25705,33,5.95 [3.31-10.70],2.618402578454315e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CD93,Complement component C1q receptor,24753,35,9.80 [5.47-17.56],1.7796484881166226e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH1,Cadherin-1,24883,36,3.31 [2.46-4.47],4.28398266445085e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH15,Cadherin-15,25919,35,2.61 [1.85-3.69],4.9294160365521626e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH17,Cadherin-17,25743,35,2.45 [1.74-3.45],2.548904168401857e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH3,Cadherin-3,25967,35,4.88 [2.96-8.04],5.003995795629073e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CDH6,Cadherin-6,25743,35,5.93 [3.16-11.13],3.052188945678743e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,22447,28,0.21 [0.14-0.31],7.429221955251188e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,26011,36,0.28 [0.19-0.43],1.1180849558286275e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,25743,35,9.84 [5.88-16.45],2.8191203198512057e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22407,29,4.43 [2.97-6.62],3.182237336884343e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGA,Chromogranin-A,22447,28,1.81 [1.41-2.33],4.009841798076605e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHGB,Secretogranin-1,25870,35,4.37 [2.74-6.96],5.972277318437487e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,25160,36,2.07 [1.59-2.70],6.294596569085662e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,22447,28,3.88 [2.33-6.46],1.8821664023547258e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,25884,34,9.41 [5.54-15.98],1.1341543272224678e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CKB,Creatine kinase B-type,22447,28,4.47 [2.56-7.81],1.4019781665558893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLC,Galectin-10,25705,35,2.06 [1.52-2.81],4.01072748436622e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,25659,35,7.42 [3.94-13.94],4.947348935587624e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,25705,33,3.49 [2.01-6.05],9.045110808250014e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,25743,35,5.94 [3.57-9.89],6.548000869770175e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPA1,Carboxypeptidase A1,26057,36,0.30 [0.20-0.44],1.96307786674645e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPB1,Carboxypeptidase B,26057,36,0.25 [0.16-0.41],4.564252571815774e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,22457,29,4.22 [2.24-7.97],8.550082765044475e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRIP2,Cysteine-rich protein 2,25571,33,2.92 [1.89-4.50],1.251793140477834e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,25571,33,3.50 [2.10-5.84],1.671200548639262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CRYBB2,Beta-crystallin B2,22407,29,1.81 [1.53-2.15],1.1794516106946773e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CSTB,Cystatin-B,25381,36,4.92 [3.24-7.49],9.541024009394969e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,22447,28,9.61 [5.22-17.68],3.633723953772969e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRB1,Chymotrypsinogen B,25740,35,0.25 [0.16-0.40],1.6775079966626452e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRC,Chymotrypsin-C,25755,33,0.26 [0.18-0.38],6.962643648727385e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,22407,29,0.23 [0.16-0.34],2.3802472480616832e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSD,Cathepsin D,24031,36,2.49 [1.72-3.62],1.4286293242466186e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CTSO,Cathepsin O,26012,34,5.41 [2.69-10.91],2.309935036239194e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",CX3CL1,Fractalkine,25571,33,5.49 [3.21-9.39],5.131573009845182e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,25967,35,7.64 [4.02-14.49],4.91384705342291e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DKK4,Dickkopf-related protein 4,25531,33,3.35 [2.45-4.58],4.0431835165334885e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DLK1,Protein delta homolog 1,26057,36,3.53 [2.11-5.92],1.644264497271544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DSC2,Desmocollin-2,25470,35,8.23 [4.58-14.81],1.9589803848016577e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTNB,Dystrobrevin beta,22287,28,3.60 [2.38-5.44],1.323294158865753e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,25620,34,8.51 [4.69-15.47],2.091831448922462e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25270,35,3.32 [1.96-5.64],8.670122108619934e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,22348,29,3.85 [2.41-6.18],2.0239625110363186e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,22416,29,3.17 [2.04-4.93],3.05917918756884e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EGFLAM,Pikachurin,22348,29,3.53 [2.24-5.57],5.940246848765124e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,24828,32,6.66 [4.06-10.91],5.3881088946304775e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25909,34,7.26 [4.03-13.07],3.893320853952039e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,26057,36,9.75 [5.37-17.67],6.484286359686993e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",25753,33,2.37 [1.87-3.00],1.1224246498682117e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",25743,35,2.40 [1.78-3.22],7.392379617394958e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",22457,29,4.10 [2.91-5.78],8.475451873448935e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",26057,36,4.60 [3.10-6.82],3.1399147980250444e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,25973,36,2.29 [1.62-3.22],2.1886899326804544e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FBLN2,Fibulin-2,22447,28,9.30 [4.38-19.77],6.779923924374249e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,25740,35,2.49 [1.79-3.46],7.09568965481001e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FCRL2,Fc receptor-like protein 2,25892,34,2.40 [1.65-3.50],4.417588574765838e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF23,Fibroblast growth factor 23,25915,34,2.11 [1.64-2.71],4.6839431887245315e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGF5,Fibroblast growth factor 5,25239,34,4.08 [2.66-6.28],1.3820057770489234e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FGL1,Fibrinogen-like protein 1,22460,29,4.40 [2.80-6.92],1.2261213523969218e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,25579,34,3.65 [2.11-6.31],3.685195772782391e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,22407,29,7.75 [3.75-16.00],3.1456343681743964e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FOLR2,Folate receptor beta,25967,35,9.72 [4.94-19.13],4.6683240651308175e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL1,Follistatin-related protein 1,21875,29,9.14 [3.83-21.83],6.226172453518897e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FSTL3,Follistatin-related protein 3,25706,33,9.52 [5.45-16.61],2.2998852255115188e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,25967,35,4.32 [2.54-7.34],6.585653217380858e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21448,27,2.50 [1.83-3.41],9.471543228025156e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GDF15,Growth/differentiation factor 15,26057,36,3.77 [2.90-4.90],4.942555874750791e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,25493,33,6.89 [3.69-12.85],1.2784708075505306e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,25571,33,6.97 [3.81-12.77],3.1685789850487325e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GM2A,Ganglioside GM2 activator,21902,27,2.14 [1.60-2.86],3.477219707896296e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GOLM2,Protein GOLM2,25967,35,6.41 [2.87-14.36],6.148531996257967e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GPR37,Prosaposin receptor GPR37,25270,35,2.91 [1.95-4.34],1.689324767788271e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",GRN,Progranulin,25622,35,8.55 [3.60-20.32],1.1778063107975618e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,25919,34,3.88 [2.89-5.19],1.0934354874704738e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,25740,35,7.93 [4.75-13.24],2.280605364490826e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,22366,29,2.28 [1.66-3.14],3.684266653109338e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",25705,33,5.72 [2.89-11.34],5.657509504246101e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HMCN2,Hemicentin-2,21938,28,5.73 [2.99-10.99],1.4653714002747326e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HNMT,Histamine N-methyltransferase,25443,33,3.25 [2.07-5.11],2.913164636554299e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,21875,29,2.54 [1.72-3.74],2.566442886282004e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,21822,29,8.03 [4.57-14.09],4.198893739871522e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,22325,29,3.07 [2.08-4.54],1.8422008597857424e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HSPB6,Heat shock protein beta-6,25954,34,9.31 [5.84-14.85],6.987858664729156e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",HYAL1,Hyaluronidase-1,25579,36,8.09 [3.64-17.97],2.836779936612655e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21802,29,3.54 [2.02-6.18],9.133824292366205e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,25620,34,4.20 [2.63-6.69],1.6628043129581332e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,26012,36,6.13 [3.65-10.30],7.887597388903014e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25397,34,5.56 [3.98-7.77],8.533236277456267e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,25613,36,8.35 [5.27-13.23],1.7402211309141565e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,26057,36,3.73 [2.36-5.90],1.9380142605960122e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,25743,35,5.50 [3.00-10.08],3.707254321104287e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,25620,34,3.04 [2.12-4.36],1.5433427124594241e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,25743,35,7.65 [4.11-14.23],1.2992449468346698e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,25875,34,5.23 [3.21-8.50],2.6631624913218443e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,25239,34,6.18 [2.90-13.14],2.27233050346996e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18BP,Interleukin-18-binding protein,25829,36,8.07 [4.67-13.96],7.555819914914435e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,26012,34,9.46 [4.50-19.90],3.1248127135670182e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL19,Interleukin-19,25098,35,2.01 [1.49-2.71],4.140709898712345e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,25973,36,4.23 [2.40-7.46],6.148776191003259e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,25535,36,5.27 [3.31-8.40],2.8214546076900866e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,25705,33,4.51 [3.00-6.79],4.72948250091786e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",INHBB,Inhibin beta B chain,21977,28,4.33 [2.52-7.44],1.1758501949434669e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGAM,Integrin alpha-M,25740,35,5.41 [2.61-11.20],5.582488981402487e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITGB2,Integrin beta-2,25578,36,8.88 [3.96-19.93],1.1878369642570605e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,25829,36,9.00 [4.29-18.89],6.415675575683964e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK11,Kallikrein-11,25593,34,3.91 [2.69-5.70],1.115396263382201e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK4,Kallikrein-4,25954,34,4.09 [3.17-5.28],1.62864524707258e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KLK6,Kallikrein-6,25795,34,7.85 [3.26-18.93],4.382175231769445e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",25669,33,2.51 [1.91-3.31],5.5689702999963126e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25753,33,3.66 [2.28-5.89],8.127411904362893e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LAMA4,Laminin subunit alpha-4,25875,34,4.35 [2.32-8.16],4.330725415557041e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,24957,36,4.08 [2.75-6.06],2.986334254655753e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LEPR,Leptin receptor,25743,35,3.97 [2.51-6.27],3.8853941639266325e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS1,Galectin-1,25743,35,5.88 [3.35-10.32],6.610917037457983e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS3,Galectin-3,25802,36,4.65 [2.59-8.34],2.461533936038782e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS4,Galectin-4,25753,33,5.65 [3.82-8.36],4.688303318086471e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LGALS9,Galectin-9,25748,34,7.04 [3.65-13.57],5.923960887695476e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,25705,33,8.06 [4.20-15.47],3.41912372613321e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25699,35,7.21 [3.30-15.77],7.508576287400847e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25239,34,3.63 [2.11-6.26],3.4780333545944008e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMNB2,Lamin-B2,22407,29,5.48 [3.20-9.39],5.529824176475233e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LMOD1,Leiomodin-1,22416,29,3.37 [2.41-4.73],1.7960920646068269e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LPO,Lactoperoxidase,24951,33,2.59 [1.82-3.69],1.424747910334818e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,25743,35,9.63 [5.20-17.87],6.515130349156063e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,26057,36,7.26 [4.03-13.05],3.631603374345411e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY6D,Lymphocyte antigen 6D,25626,33,3.71 [2.36-5.83],1.2985612847613664e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,25468,34,7.39 [3.35-16.28],6.993180509216995e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",LY96,Lymphocyte antigen 96,25571,33,3.26 [2.02-5.26],1.2271352463697797e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,22457,29,7.39 [3.89-14.03],9.719740475064131e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MATN2,Matrilin-2,25797,33,7.22 [3.08-16.95],5.558411857363819e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MB,Myoglobin,26057,36,2.78 [2.01-3.84],5.478625965896924e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,25829,36,5.67 [3.18-10.10],3.9134523721773015e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MDK,Midkine,25756,34,2.05 [1.58-2.67],7.574368302387253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,26012,34,7.60 [3.25-17.76],2.77404767672433e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,26057,36,7.48 [3.99-14.02],3.3226620302684247e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MILR1,Allergin-1,25239,34,2.86 [1.84-4.46],3.4459399175085503e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP10,Stromelysin-2,25710,33,2.33 [1.65-3.29],1.5310493170875187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP12,Macrophage metalloelastase,25750,34,3.73 [2.48-5.61],2.2929395556934126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP13,Collagenase 3,25133,33,7.04 [3.56-13.95],2.1948647270737525e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MMP7,Matrilysin,25226,35,4.80 [2.71-8.50],7.28120234049776e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,25954,34,7.92 [3.74-16.77],6.605633228185375e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,25967,35,4.46 [2.74-7.26],1.8975712439135237e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MUC13,Mucin-13,25133,33,4.34 [2.98-6.34],2.72526680970628e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",22457,29,2.46 [1.78-3.40],4.596660049419113e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",21875,29,1.69 [1.40-2.03],3.7082491844706414e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MYOM3,Myomesin-3,21977,28,2.20 [1.56-3.11],7.146917386902319e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,25840,33,2.75 [1.76-4.30],8.202631866030336e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,25666,33,9.63 [5.25-17.70],2.8238714367582813e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NECTIN4,Nectin-4,25832,34,6.60 [4.41-9.88],4.632603036760353e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NEFL,Neurofilament light polypeptide,25050,33,5.13 [3.63-7.25],1.8369013872202222e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,25832,34,0.19 [0.10-0.34],5.6827450805199176e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,25875,34,6.84 [3.22-14.52],5.641564545782961e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",25133,33,4.04 [2.79-5.87],1.75037605401592e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,22063,28,3.83 [2.55-5.76],1.0055370973949879e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,25743,35,7.62 [4.93-11.76],4.894014032686871e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,25743,35,8.67 [4.52-16.65],8.612951212302407e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,22407,29,2.71 [1.85-3.95],2.4257654875844454e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,25743,35,1.99 [1.58-2.50],2.9559796852866517e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OCLN,Occludin,22416,29,4.51 [2.87-7.07],5.4527220599867305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",OLFM4,Olfactomedin-4,21155,26,2.08 [1.61-2.69],1.785902857265683e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM,Paralemmin-1,22232,28,8.80 [4.92-15.74],2.2381079844670174e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PALM2,Paralemmin-2,22407,29,5.49 [3.58-8.44],7.300471534475006e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH1,Protocadherin-1,25930,34,4.17 [2.30-7.57],2.764093643824006e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDH17,Protocadherin-17,25743,35,6.10 [3.48-10.69],2.52789592026096e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PCDHB15,Protocadherin beta-15,22325,29,2.69 [1.74-4.17],8.923414336453059e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1,Programmed cell death protein 1,25917,34,3.10 [2.11-4.55],8.510205828837155e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,25620,34,6.55 [4.03-10.65],3.701834508084835e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PENK,Proenkephalin-A,21977,28,3.68 [2.32-5.84],2.9538801833286562e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PGF,Placenta growth factor,26012,34,4.12 [2.75-6.19],7.155091793349339e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,25571,33,7.38 [3.47-15.70],2.117396880844156e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PI3,Elafin,25388,36,2.57 [1.96-3.39],1.3369315147238419e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25406,35,9.94 [5.62-17.60],3.176232565327892e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,25740,35,7.19 [3.91-13.23],2.1763523940202447e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,25743,35,4.90 [2.72-8.83],1.270739846138689e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G1B,Phospholipase A2,26010,36,0.24 [0.14-0.41],1.1568993498781748e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,25740,35,0.29 [0.18-0.49],1.8935204938058128e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,22460,29,0.24 [0.16-0.37],1.2043705057722503e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",POF1B,Protein POF1B,21822,29,2.82 [2.04-3.90],3.1620493264161126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,25895,36,3.93 [2.48-6.23],5.629132982854956e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRG2,Bone marrow proteoglycan,22447,28,3.79 [2.35-6.13],4.950823472715867e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRND,Prion-like protein doppel,22407,29,2.99 [1.92-4.66],1.2460629406768863e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,21875,29,4.92 [2.52-9.61],3.074963675612762e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS27,Serine protease 27,25659,35,4.29 [2.32-7.92],3.2753470124175344e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRSS8,Prostasin,25661,34,4.55 [2.44-8.46],1.7481589296452367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PRTG,Protogenin,25954,34,9.86 [3.91-24.85],1.2396062993476395e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,25571,33,2.87 [2.19-3.75],1.7559023417610587e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,25532,36,8.85 [5.91-13.24],3.026382312745014e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,25133,33,4.24 [2.79-6.45],1.4354352912823093e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,25775,36,8.06 [4.41-14.71],1.1358089594197854e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22416,29,3.63 [2.58-5.11],1.4009373217616597e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RBP2,Retinol-binding protein 2,25620,34,2.79 [2.05-3.79],6.912842335314124e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1A,Lithostathine-1-alpha,25576,36,3.83 [2.90-5.07],3.640546940072673e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG1B,Lithostathine-1-beta,26057,36,2.53 [1.88-3.40],7.090749812165819e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,26057,36,3.18 [2.32-4.37],8.796248770897867e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REG4,Regenerating islet-derived protein 4,25797,33,7.13 [4.64-10.96],3.1805684904027456e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",REN,Renin,25743,35,3.45 [2.77-4.30],3.790280801790303e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RETN,Resistin,25675,36,3.84 [2.52-5.87],4.6154048546016557e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE1,Ribonuclease pancreatic,22460,29,4.64 [2.77-7.75],4.8466718979576075e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,21875,29,2.08 [1.53-2.84],3.5781006023424884e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE4,Ribonuclease 4,21704,28,3.90 [2.13-7.12],9.645407598626568e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASE6,Ribonuclease K6,22292,29,3.30 [2.38-4.57],7.522192743017839e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNASET2,Ribonuclease T2,25931,36,7.48 [4.47-12.53],2.0619326691927204e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,21875,29,6.71 [3.10-14.53],1.3576028626927685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ROBO1,Roundabout homolog 1,25797,33,8.34 [4.00-17.38],1.513554767220429e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",RSPO3,R-spondin-3,25954,34,9.73 [4.97-19.02],3.0003465251043736e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",S100P,Protein S100-P,25270,35,2.04 [1.53-2.72],1.0226765332846262e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCARB2,Lysosome membrane protein 2,25104,33,8.92 [5.67-14.04],2.9024906568494335e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCGN,Secretagogin,25239,34,3.93 [2.67-5.77],3.167079670373741e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,21875,29,5.36 [2.97-9.67],2.3245040043759056e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,22457,29,5.33 [2.74-10.35],7.706910888879971e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SDC1,Syndecan-1,25743,35,2.75 [1.83-4.15],1.305981859749205e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,21875,29,2.58 [1.81-3.67],1.582361895576414e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEMA7A,Semaphorin-7A,25973,36,5.07 [3.17-8.10],1.079278579946732e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SEPTIN8,Septin-8,22362,29,5.36 [3.11-9.22],1.425723373047025e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,25492,33,2.64 [1.78-3.89],1.1263665570974103e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,21977,28,9.18 [4.19-20.10],2.956244509829216e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SHISA5,Protein shisa-5,22447,28,5.14 [3.11-8.48],1.5216024767153912e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC1,Sialoadhesin,25875,34,4.04 [2.44-6.70],6.041809738507998e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,25705,33,5.05 [3.03-8.41],4.730698980163324e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,25954,34,3.25 [2.01-5.26],1.5453790194104365e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,25743,35,5.91 [2.87-12.18],1.4329798379617474e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,21875,29,4.44 [2.30-8.58],9.021460720417075e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,25716,33,5.49 [3.22-9.38],4.4687026285839183e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLAMF8,SLAM family member 8,25147,34,3.16 [2.01-4.97],5.724373824517442e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,25133,33,2.79 [1.80-4.34],5.048430634496136e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,25270,35,3.33 [2.07-5.35],6.402651616275498e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,25954,34,8.02 [4.19-15.33],3.1965286283723576e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,25875,34,5.17 [3.38-7.91],3.4744429202771145e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SNCG,Gamma-synuclein,25571,33,5.42 [3.63-8.10],1.7080666905338212e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,25147,34,5.82 [3.55-9.55],3.1729313562307253e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,25740,35,3.81 [2.64-5.49],8.17707830357242e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,25705,33,3.20 [2.32-4.41],1.3119080258357253e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPON1,Spondin-1,25797,33,3.96 [2.44-6.43],2.4027811334164643e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SPP1,Osteopontin,26012,36,4.73 [3.02-7.40],1.0091416784196111e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,22457,29,9.98 [4.99-19.95],7.544251969773336e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",STC1,Stanniocalcin-1,25967,35,4.01 [2.71-5.93],4.10112014369585e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,21844,28,9.28 [3.65-23.62],2.9377794127644696e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,25620,34,8.49 [5.36-13.46],8.924645888758353e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TCN2,Transcobalamin-2,26012,36,3.81 [2.39-6.07],1.7696542505714254e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF1,Trefoil factor 1,25610,35,2.51 [1.96-3.23],5.675668120581744e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF2,Trefoil factor 2,25832,34,3.64 [2.59-5.12],1.0475806636859285e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFF3,Trefoil factor 3,25711,36,2.50 [1.92-3.27],1.494707630385293e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,25746,34,1.92 [1.44-2.55],8.409450128185966e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,25832,34,9.13 [5.98-13.95],1.4807774407417288e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,26057,36,7.05 [3.34-14.91],3.165783332704409e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS2,Thrombospondin-2,25740,35,3.25 [1.96-5.39],5.154713404804936e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",THBS4,Thrombospondin-4,25738,36,4.48 [2.57-7.82],1.289066695665082e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,25446,36,5.32 [2.84-9.95],1.7747112098228833e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,25740,35,3.03 [1.93-4.76],1.4237275253471626e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,22362,29,2.71 [1.78-4.12],3.068230339138417e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25571,33,4.31 [3.02-6.17],1.0660425679032452e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25571,33,1.88 [1.56-2.26],3.8565354418447015e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,26012,34,8.18 [5.39-12.42],5.836870988607845e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25753,33,9.59 [5.05-18.22],5.03046286857282e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25832,34,7.50 [4.39-12.82],1.691533323016282e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,25954,34,8.60 [5.44-13.60],3.436049058545409e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25740,35,2.59 [2.03-3.31],2.7918941185591355e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,25968,34,5.27 [3.47-8.00],5.991062074400369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25571,33,2.57 [1.92-3.44],2.080803725499216e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,25967,35,3.13 [2.07-4.73],6.625323841910275e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25571,33,3.81 [2.83-5.12],8.172239855068283e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",ULBP2,UL16-binding protein 2,25571,33,5.81 [3.49-9.66],1.1668750932468076e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",UMOD,Uromodulin,25985,34,0.28 [0.19-0.42],1.339143353974846e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,25784,36,7.09 [3.35-15.02],3.085774639479164e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,21822,29,8.61 [4.18-17.71],4.922367360919655e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,25964,34,7.43 [3.30-16.71],1.2656463349718542e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VIT,Vitrin,22457,29,4.46 [2.64-7.54],2.2652561639820654e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22325,29,2.79 [1.89-4.11],2.2286528615761325e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,25705,34,6.17 [4.16-9.16],1.8642412484602584e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24422,34,5.90 [3.99-8.73],5.506104276535637e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",WNT9A,Protein Wnt-9a,25239,34,5.83 [3.64-9.36],2.601937469930852e-13
